Mark Owens Thornton
Keine laufenden Positionen mehr
Profil
Mark Owens Thornton worked as a Managing Director-Clinical & Regulatory Affairs at Angiotech Pharmaceuticals, Inc. from 2005 to 2006.
He then worked as a Director at Excel-Tech Ltd.
from 2006 to 2007.
From 2006 to 2010, he was a Senior Vice President-Product Development at GenVec, Inc. Prior to that, he was the Chief Medical Officer at ZIOPHARM, Inc. from 2001 to 2005.
Thornton's education includes a graduate degree from The Johns Hopkins University and a doctorate degree from West Virginia University.
Ehemalige bekannte Positionen von Mark Owens Thornton
| Unternehmen | Position | Ende |
|---|---|---|
| GENVEC INC | Corporate Officer/Principal | 23.05.2010 |
Excel-Tech Ltd.
 Excel-Tech Ltd. Medical SpecialtiesHealth Technology Excel-Tech Ltd. engages in the manufacture of musculoskeletal therapy equipment. It designs and produces neuromuscular and neurophysiological instruments. Its IP-enabled medical solutions address the complete spectrum of monitoring and diagnosis of conditions affecting the central and peripheral nervous systems. The company was founded by John Mumford in 1985 and is headquartered in Oakville, Canada. | Direktor/Vorstandsmitglied | 30.11.2007 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
| ZIOPHARM, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
| NOVAVAX, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Mark Owens Thornton
| The Johns Hopkins University | Graduate Degree |
| West Virginia University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| ZIOPHARM, Inc. | Health Technology |
Excel-Tech Ltd.
Excel-Tech Ltd. Medical SpecialtiesHealth Technology Excel-Tech Ltd. engages in the manufacture of musculoskeletal therapy equipment. It designs and produces neuromuscular and neurophysiological instruments. Its IP-enabled medical solutions address the complete spectrum of monitoring and diagnosis of conditions affecting the central and peripheral nervous systems. The company was founded by John Mumford in 1985 and is headquartered in Oakville, Canada. | Health Technology |
